Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Based on Japanese GAAP)
TOWA PHARMA, Apr-Dec (Cumulative 3Q) Ordinary Profit Increases by 10%, Oct-Dec Ordinary Profit Increases by 5%
Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Based on Japanese GAAP)
Consolidated Financial Results for the Nine Months Ended December 31, 2025 (Based on Japanese GAAP)
Supplementary material for the financial results for the third quarter of the year ending March 31, 2026